The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Home > Documents > Notification of "Sofprint group"AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD as of 14 June 2024
Notification of "Sofprint group"AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD as of 14 June 2024